Tecan uses cookies to improve our website. By continuing to browse our website, you accept our cookie policy.
Tecan uses cookies to improve our website. By continuing to browse our website, you accept our cookie policy.
Multiple myeloma (MM) remains an incurable blood cancer, but recent advancements in treatment have significantly improved patient prognosis and quality of life. UK-based specialist diagnostic company The Binding Site has developed a new strategy...
Ralf Griebel, Head of the Partnering Business Division
Tecan is collaborating with Luminex® Corporation to develop an innovative, automated newborn screening solution designed to rapidly identify potential health issues in infants. Luminex’s Luminex 200™ instrument with xMAP® technology is being...
Tecan has been working with Applied Biosystems, part of Life Technologies Corporation to develop an off-the-shelf system for automated bead washing, based on a Freedom EVO® 75 workstation equipped with a Te-MagS™ separation module.
Tecan and FortéBio have worked together to integrate the new FortéBio Octet® 384 platform on the Freedom EVO® workstation for automated real-time, label-free assays to support bioprocessing and drug discovery workflows. Tecan has collaborated with...